dlbhattmd.bsky.social
Dr. Deepak L. Bhatt
@dlbhattmd.bsky.social
58 followers 32 following 11 posts
Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, is the Director of the Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine (with Tenure) at the Icahn School of Medicine at Mount Sinai in New York City.
Posts Media Videos Starter Packs
dlbhattmd.bsky.social
Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 20d
Mount Sinai Fuster Heart Hospital celebration of our #2 national ranking in US News & World Report. #cardiology #cardiovascular
1 3
dlbhattmd.bsky.social
Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · Jul 1
Welcome to our new #cardiology fellows at Mount Sinai Hospital!
3
dlbhattmd.bsky.social
Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · May 22
Just out in @science.org Translational Medicine - more data supporting the pleiotropic benefits of EPA: Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1–induced platelet reactivity www.science.org/doi/10.1126/... #cardiology #CardioSky #cardiovascular #MedSky #EndoSky
Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1–induced platelet reactivity
Dose-dependent platelet inhibition by icosapent ethyl contributes to beneficial effects of polyunsaturated omega-3 fatty acids.
www.science.org
5 6
dlbhattmd.bsky.social
Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · May 14
#cardiology #cardiovascular #MedSky #EndoSky #CardioSky #RenalSky @thelancetendo.bsky.social @thelancet.bsky.social
thelancetendo.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · Apr 11
The ischaemic benefit on both myocardial infarction & stroke has not been previously observed with other SGLT inhibitors & warrants investigation of combined SGLT1/SGLT2 inhibition as a possible underlying mechanism thelancet.com/journals/lan...
#T2D #CVD #CKD
#MedSky #EndoSky #CardioSky #RenalSky
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Sotagliflozin reduced MACE, with independent reductions in myocardial infarction and stroke, among patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk. The ischae...
thelancet.com
4 3
dlbhattmd.bsky.social
Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · May 14
#cardiology #cardiovascular #MedSky #CardioSky
skraler.bsky.social
Simon Kraler @skraler.bsky.social · May 14
🚨 Now up
@escardio.bsky.social

Acute coronary syndromes: together w/
@dlbhattmd.bsky.social, C Mueller & P Libby we call for a precision medicine approach

🔹 Diverse mechanisms
🔹 Sex-specific differences
🔹 Shifting risk factor profiles
🔹 AI tools for personalised care

doi.org/10.1093/eurh...
2 2
dlbhattmd.bsky.social
Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · May 14
Congratulations and great job, @skraler.bsky.social!
2
dlbhattmd.bsky.social
Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · Apr 30
#Education #MBA #EMBA
ox.ac.uk
University of Oxford @ox.ac.uk · Apr 30
NEW: Oxford University's Executive MBA (EMBA) programme from the Said Business School has been ranked as the best in the world by QS for the second consecutive year 🏆

Read more ⬇️
Oxford’s Executive MBA ranked world number one by QS | University of
The University of Oxford’s Executive MBA (EMBA) programme from the Saïd Business School has been ranked as the best in the world by QS for the second consecutive year.
www.ox.ac.uk
2
dlbhattmd.bsky.social
Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · Apr 27
Potential impact of the ongoing VICTORION-1 PREVENT trial - bottom line, millions of patients could be eligible for therapy with inclisiran. #CardioSky #MedSky #Cardiology #Cardiovascular #Prevention @ajpcardio.bsky.social
ajpcardio.bsky.social
American Journal of Preventive Cardiology @ajpcardio.bsky.social · Apr 25
>23 million US adults meet criteria for the ongoing trial of inclisiran for primary prevention (VICTORION-1 Prevent), yet rates of lipid-lowering therapy use are low among this high-risk population.

www.sciencedirect.com/science/arti...

#CardioSky #MedSky
1 2
dlbhattmd.bsky.social
Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · Apr 25
Wonderful 19th VF Society meeting last night at The New York Academy of Medicine! #cardiology #cardiovascular
2 3
dlbhattmd.bsky.social
Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · Apr 24
Calibration of ECG-Based Deep-Learning Algorithm Scores for Patients Flagged as High Risk for Hypertrophic Cardiomyopathy | NEJM AI ai.nejm.org/doi/full/10.... #cardiology #AI
Calibration of ECG-Based Deep-Learning Algorithm Scores for Patients Flagged as High Risk for Hypertrophic Cardiomyopathy
Despite optimism for the incorporation of deep-learning (DL) algorithms into clinical practice, there is a lack of prospective data on how U.S. Food and Drug Administration (FDA)–cleared algorithms...
ai.nejm.org
1 2 3
dlbhattmd.bsky.social
Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · Apr 23
Key Insights for Thromboembolic Disease Prevention, now available online at ms.spr.ly/6012W7yq8 #cardiology #cardiovascular #CME @medscape.com @medscape.org
AHA Conference Recap: Key Insights for Thromboembolic Disease Prevention
Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.
ms.spr.ly
1 2 2